171 related articles for article (PubMed ID: 29216842)
1. A clinical tool to predict Plasmodium vivax recurrence in Malaysia.
Mat Ariffin N; Islahudin F; Kumolosasi E; Makmor-Bakry M
BMC Infect Dis; 2017 Dec; 17(1):759. PubMed ID: 29216842
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Plasmodium vivax malaria recurrence in Brazil.
Daher A; Silva JCAL; Stevens A; Marchesini P; Fontes CJ; Ter Kuile FO; Lalloo DG
Malar J; 2019 Jan; 18(1):18. PubMed ID: 30670020
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
[TBL] [Abstract][Full Text] [Related]
4. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
[TBL] [Abstract][Full Text] [Related]
5. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vivax malaria on the western border of Thailand.
Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
[TBL] [Abstract][Full Text] [Related]
7. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
Taylor AR; Watson JA; Chu CS; Puaprasert K; Duanguppama J; Day NPJ; Nosten F; Neafsey DE; Buckee CO; Imwong M; White NJ
Nat Commun; 2019 Dec; 10(1):5595. PubMed ID: 31811128
[TBL] [Abstract][Full Text] [Related]
8. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
Douglas NM; Poespoprodjo JR; Patriani D; Malloy MJ; Kenangalem E; Sugiarto P; Simpson JA; Soenarto Y; Anstey NM; Price RN
PLoS Med; 2017 Aug; 14(8):e1002379. PubMed ID: 28850568
[TBL] [Abstract][Full Text] [Related]
9. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
Goller JL; Jolley D; Ringwald P; Biggs BA
Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in South and South-East Iran, 2008-2011.
Miahipour A; Keshavarz H; Heidari A; Raeisi A; Rezaeian M; Rezaei S
Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):420-6. PubMed ID: 23694816
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
12. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
[TBL] [Abstract][Full Text] [Related]
13. A Malaria Case Followed By Relapse.
Sümer Ş; Aktuğ Demir N; Ural O; Çimen G; Yalçınkaya E
Turkiye Parazitol Derg; 2018 Jun; 42(2):161-163. PubMed ID: 29780011
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
[TBL] [Abstract][Full Text] [Related]
15. Severe Plasmodium vivax malaria, Brazilian Amazon.
Alexandre MA; Ferreira CO; Siqueira AM; Magalhães BL; Mourão MP; Lacerda MV; Alecrim Md
Emerg Infect Dis; 2010 Oct; 16(10):1611-4. PubMed ID: 20875292
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM
Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633
[TBL] [Abstract][Full Text] [Related]
17. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
[No Abstract] [Full Text] [Related]
18. Interactive medical case. A chilly fever.
Redig AJ; Vaidya A; Price C; Katz JT; Maguire JH
N Engl J Med; 2014 Oct; 371(16):e24. PubMed ID: 25317891
[No Abstract] [Full Text] [Related]
19. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.
Golassa L; Baliraine FN; Enweji N; Erko B; Swedberg G; Aseffa A
BMC Infect Dis; 2015 Aug; 15():310. PubMed ID: 26242405
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
Spudick JM; Garcia LS; Graham DM; Haake DA
J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
